Neoplasms are characterized as either benign or malignant tumors. Benign tumors remain localized and do not invade surrounding tissue, while malignant tumors grow uncontrollably, invade surrounding areas, and metastasize to distant sites. Cancer development occurs through genetic mutations that alter cell growth and behavior over time. Malignant tumors are further classified by their site of origin, structure, and degree of differentiation through grading and staging systems.
A tumor marker is a substance found in your blood, urine, or body tissue. The term "tumor markers" may refer to proteins that are made by both healthy
....
Neoplasia - Characteristics & Classification of Neoplasm Chhavi Singh
This power point presentation take a detail note on neoplasm (cancer), types of neoplasm, stages of neoplasm, various kinds of carcinogens. This presentation also take interest in the classification and characteristics of the tumor & difference between the normal cells and tumor cells.
Oncology - For nursing students - tumors classification, cancer, differences between benign and malignant neoplasm,spread of cancer, pathophysiology with cancer cells, carcinogenesis, etiology, cancer screening, cancer prevention, management of cancer, radiation therapy, chemotherapy, bone marrow transplantation, oncologic emergencies
Introduction
Tumours
Types of Tumours
Formation of Tumours
How cancer cell differ from normal cells
Classification of cancer
The causes of cancer
Viruses and Cancer
Cancer and Gene: A. Oncogene
B. Tumours suppressor gene
Detection and Diagnosis
Therapy of cancer
How can cancer are prevented
Conclusion
References
CANCER: A REVIEW: WORLD'S SECOND MOST FEARED DIAGNOSISCharu Pundir
It is a basic review presentation on cancer, world's second most dreadful disease followed by cardiovascular events, involving basic defination, pathophysiology, screening methods, types of tumor, tumor origin, cancer cell lines, treatment, recent advancements made in the field and diagnosis.
A tumor marker is a substance found in your blood, urine, or body tissue. The term "tumor markers" may refer to proteins that are made by both healthy
....
Neoplasia - Characteristics & Classification of Neoplasm Chhavi Singh
This power point presentation take a detail note on neoplasm (cancer), types of neoplasm, stages of neoplasm, various kinds of carcinogens. This presentation also take interest in the classification and characteristics of the tumor & difference between the normal cells and tumor cells.
Oncology - For nursing students - tumors classification, cancer, differences between benign and malignant neoplasm,spread of cancer, pathophysiology with cancer cells, carcinogenesis, etiology, cancer screening, cancer prevention, management of cancer, radiation therapy, chemotherapy, bone marrow transplantation, oncologic emergencies
Introduction
Tumours
Types of Tumours
Formation of Tumours
How cancer cell differ from normal cells
Classification of cancer
The causes of cancer
Viruses and Cancer
Cancer and Gene: A. Oncogene
B. Tumours suppressor gene
Detection and Diagnosis
Therapy of cancer
How can cancer are prevented
Conclusion
References
CANCER: A REVIEW: WORLD'S SECOND MOST FEARED DIAGNOSISCharu Pundir
It is a basic review presentation on cancer, world's second most dreadful disease followed by cardiovascular events, involving basic defination, pathophysiology, screening methods, types of tumor, tumor origin, cancer cell lines, treatment, recent advancements made in the field and diagnosis.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
2. Definition
that
• Neoplasia means ‘new growth’
• Neoplasm means ‘tumour/ cancer’
• Cancer is an uncontrolled proliferation of cells
express varying degree of fidelity to their precursors.
• It can be benign or malignant.
• Benign: Cells grow as a compact
mass and remain at their site of
origin
• Malignant:
Growth of cells is uncontrolled
Cells can spread into surrounding
tissue and spread to distant sites.
4. Cellular adaptations
• Atrophy: Reduction of number and size of parenchymal cells
of an organ or its parts which was once normal is called
atrophy. E.g.: ischemic atrophy, neuropathic atrophy.
• Hypertrophy: Increase is an size of parenchymal cells resulting
in enlargement of the organ. E.g.: enlarged size of uterus in
pregnancy (physiological), hypertrophy of cardiac muscle
(pathological).
5. Cellular adaptations
• Hyperplasia: Increased number of parenchymal cells resulting
in enlargement of the organ. E.g.: Hyperplasia of female
breast at puberty, pregnancy and lactation
during
(physiological), wound healing (pathological; formation of
granulation tissue due to proliferation of fibroblasts and
endothelial cells)
• Dysplasia: Disordered cellular development (pleomorphism,
nuclear hyperchromasia, mitosis, loss of polarity)
accompanied with metaplasia and hyperplasia.
• Metaplasia: Reversible changes in one type of epithelial or
epithelial or
mesenchymal adult cell to another type of
mesenchymal adult cell .
– Epithelial Squamous and Columnar metaplasia
– Mesenchymal Osseous and Cartilaginous metaplasia
7. Differences between benign and
malignant neoplasms
BENIGN MALIGNANT
Nuclear variation in
size and shape
minimal
Nuclear variation in size and
shape minimal to marked,
often variable
Diploid Range of ploidy
Low mitotic count,
normal mitosis
Low to high mitotic count,
abnormal mitosis
Retention of
specialisation
Loss of specialisation
Structural
differentiation
retained
Structural differentiation shows
wide range of changes
Organised Not organised
Functional
differentiation
usually
Functional differentiation often
lost
8. Causes of cancer
Three major type of carcinogens
Chemical carcinogenesis
• Mutagens
• Chemical carcinogenesis and their metabolism
Physical carcinogenesis (radiation)
• Ultraviolet radiation, Asbestos
Infectious Pathogens (Viral)
• Human T-cell leukemia viruses, DNA
viruses, Human papillomaviruses
• Epstein-Barr virus, Hepatitis B virus
9. Development of cancer
• Changes in DNA (mutation)
• The change must cause an alteration in cell growth and behaviour
• The change must be non-lethal and be passed onto daughter cells
• Alterations in more than one gene
• Genes concerned are oncogenes/tumour suppressor genes
• Sequence of gene alterations from normal to benign to malignant
• Intrinsic and extrinsic / inheritance and environment key factors
10.
11. Properties of cancer cells
• Tow unique properties of cancer cells are
– ability to invade locally
– capacity to metastasize to distant sites to distant sites – cancer
spreading (patterns of spread)
Patterns of spread:
Direct extension: Carcinomas begin as
localized growths (direct seeding of body
cavities or surface), when they arise. In
early cancers do not penetrate the
basement membrane (carcinoma in situ).
When the in situ tumor acquires invasive
potential extends directly to compromise
neighboring cells and to metastasize. E.g.
Peritoneal carcinomatosis (metastatic
ovarian carcinoma)
12. Properties of cancer cells
• Patterns of spread:
– Direct extension
– Metastatic spread: Transfer of
malignant cells from one site to
another (not directly connected
with it). Invasive properties of
malignant tumors bring them into
contact with blood and lymphatic
vessels.
• Hematogenous metastases
• Lymphatic metastases
13. Nomenclature
• Benign tumors:
– Suffix- oma to cell of origin
– Name of origin cell + morphologic
pailoma, ovarian cyst adenoma)
character + oma (skin
– E.g.:
• tumors of squamous epithelium- epithelioma
• tumors arising from the glandular gland (colon/ endocrine glands)-
adenoma
– lipoma ,fiboma, chondroma, osteoma papilloma
14. Nomenclature
• Malignant tumors:
– mesenchymal tissue are usually called sarcoma
– Epithelial cell origin are usually called carcinoma
– Name of origin cell + morphologic character + carcinoma/
sarcoma
– E.g.:
• Malignant tumor of the stomach is a gastric adenocarcinoma or
adenocarcinoma of the stomach.
15. Special nomenclature
• Blastoma: tumors rigging in immature tissue or nervous
tissue, most of them are malignant
– E.g.: medulloblastoma, retinoblastoma, nephroblastoma
• Some tumors ataching the suffix- oma, but they are malignant
Malignant tumor of the liver: Hepatoma
Melanoma of the skin
Lymphoproferative tumor: Lymphoma (Hodgkin’s
and non Hodgkin’s)
Malignant proliferation of leukocytes: Leukemia
16. Special nomenclature
• Mixed tumors: Derived from one from one germ layer
may undergo divergent defferentiation creating
– E.g.: Mixed tumor of salivary gland
• Teratomas: Tumors containing mature or immature cells
• Hamartoma: tumor-like malformation composed of a
haphazard arrangement of tissues indigenous to the
particular site, which is totally benign.
25. Characteristics of tumours
• Majority of neoplasms can be categorized clinically and
morphological into benign and malignant on the basis of
certain characteristics listed bellow
– Rate of growth
– Cancer phenotype and stem cells
– Clinical and gross features
– Microscopic features
– Local invasion (direct spread)
– Metastasis (distant spread)
26. Characteristics of tumours
• Rate of growth
– The tumour cell proliferate more rapidly than the normal cells.
– The tumour enlarge rate is depends upon
1. Rate of cell production, growth fraction and rate of cell loss
2. Degree of differentiation of the tumour
1. Rate of growth of a tumour depends upon
• Doubling time (mitotic rate) of tumour cells
• Number of cells remaining in preoperative pool (growth fraction)
• Rate of loss of tumour cells by cell shedding
Cancer cell do not follow the normal cell controls in cells, and are immortal.
The cell division rate is high and center of tumor do not receive adequate
nourishment and undergo ischemic necrosis, loss shedding.
Death tumour cells appear as apoptotic figures and dividing tumours are
seen as normal/ abnormal mitotic figure ultimately tumour grow in size.
27. Characteristics of tumours
• Rate of growth
2. Degree of differentiation
• Rate of growth of malignant tumour is directly proportionate to the
degree of differentiation.
• Poorly differentiated tumours show aggressive growth pattern
compare to better differentiated tumours.
• Rarely, a malignant tumour may disappear spontaneously from the
primary site, due to good host immune attack.
28. Characteristics of tumours
• Cancer phenotype and stem cells
Cancer cells
1. disobey the growth control – proliferate rapidly
2. escape from death signals – immortality
3. imbalance between cell proliferation and cell death – excessive growth
4. lose differentiation properties – no function
5. are unstable – newer mutations
6. overrun their neighboring tissue – invade locally
7. have the ability to travel from the site of origin to other part of body –
distant metastasis
Cancer stem cells/ tumour-initiating cells have the properties of self-renewal,
asymmetric replication and transdifferentiation (i.e. plasticity).
29. Characteristics of tumours
• Clinical and gross features
– Benign tumour are generally slow growing and depending
upon location remains asymptomatic (subcutaneous lipoma)
or may cause serous symptoms (meningioma in the nervous
system). Benign tumours are generally spherical or ovoid
shape.
– Malignant tumor grow rapidly, invade locally into deeper
tissue and spread to distant sites (metastasis). Malignant
tumours are usually irregular in shape, poor-circumscribed
and extend into adjacent tissues.
30. Characteristics of tumours
• Microscopic features
– Microscopic pattern
– Cytomorphology of neoplastic cells
– Tumor angiogenesis and stroma
– Inflammatory reaction
31. Characteristics of tumours
• Local invasion (direct spread)
– Benign: expand and push aside without invading, infiltrating
or metastasising.
– Malignant: expand, invasion, infiltration and destruction of
the surrounding tissue.
• Metastasis (distant spread)
– Metastasis (meta= transformation, stasis= residence): spread
of tumour by invasion.
– Routes of metastasis
• Lymphatic spread
• Haematogenous spread
• Spread along body cavities and natural passages
32.
33. Tumours grading
Grading is based on (1) the degree of anaplasia
(2) the rate of growth
• Grade-I : Well-differentiated (less than 25% anaplastic cells)
• Grade-II : Moderately-differentiated (25-50% anaplastic cells)
• Grade-III : Moderately-differentiated (50-75% anaplastic cells)
• Grade-IV : Poorly-differentiated or anaplastic (more than 75%
anaplastic cells)
34. Tumours staging
• International TNM system is commonly used for solid
tumours (less applicable to lymphomas and leukaemias).
– T: Tumour (size of primary tumour), N: Nodes (local/ regional
node involvement), M: Metastases (distant metastases)
T0 No evidence of tumour N0 Regional lymph nodes not involved
Tis Carcinoma in situ NX Regional lymph nodes can’t be
assessed
TX Tumour can’t be
assessed
N1-4 Progressive increase in number of
local/ regional lymph nodes involved
T1-4 Progressive increase in
tumour size
M0 No evidence of distant metastases
MX distant metastases can’t be assessed
M1-3 Increasing involvement of distant
metastases